Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020

BACKGROUND: To control epidemic waves, it is important to know the susceptibility to SARS-CoV-2 and its evolution over time in relation to the control measures taken. AIM: To assess the evolving SARS-CoV-2 seroprevalence and seroincidence related to the first national lockdown in Belgium, we perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Herzog, Sereina Annik, De Bie, Jessie, Abrams, Steven, Wouters, Ine, Ekinci, Esra, Patteet, Lisbeth, Coppens, Astrid, De Spiegeleer, Sandy, Beutels, Philippe, Van Damme, Pierre, Hens, Niel, Theeten, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895468/
https://www.ncbi.nlm.nih.gov/pubmed/35241216
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895468/
https://www.ncbi.nlm.nih.gov/pubmed/35241216
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419

Ejemplares similares